BAY 81-8973, a full-length recombinant factor VIII for the treatment of hemophilia A: product review

Johnny N. Mahlangu, Sanjay P. Ahuja, Jerzy Windyga, Nikki Church, Anita Shah, Lawrence Schwartz
  • Therapeutic Advances in Hematology, June 2018, SAGE Publications
  • DOI: 10.1177/2040620718777903

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1177/2040620718777903

In partnership with: